Lipid Panel Testing Market Analysis Through 2030 Focusing On Demand Trends And Growth Drivers

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Lipid Panel Testing Market From 2026 To 2030?

The lipid panel testing market has experienced substantial growth in recent years. It is anticipated to expand from $11.61 billion in 2025 to $12.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.6%. Historically, this growth has been fueled by the increasing prevalence of cardiovascular diseases, the expansion of routine health screening programs, growing awareness of cholesterol management, the adoption of automated laboratory diagnostics, and improved access to diagnostic services.

The lipid panel testing market is projected to experience robust expansion over the coming years. It is forecast to attain a value of $17.79 billion by 2030, advancing at a compound annual growth rate (CAGR) of 9.0%. This market’s expansion throughout the forecast period is driven by an escalating emphasis on preventive healthcare, a growing need for home diagnostics, the integration of digital health platforms, the increasing utilization of AI-assisted diagnostic interpretation, and the broadening of population health screening initiatives. Significant trends expected during this period involve the rising adoption of point-of-care lipid testing, increased deployment of automated lipid analyzers, a surging demand for preventive cardiovascular screening, the wider availability of home-based lipid testing kits, and a greater concentration on early risk assessment.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10270&type=smp

What Key Growth Drivers Are Influencing The Lipid Panel Testing Market?

The increasing occurrence of cardiovascular and diabetic illnesses is anticipated to drive the expansion of the lipid panel testing market in the future. Cardiovascular ailments encompass various conditions impacting the heart and blood vessels, whereas diabetes is a persistent metabolic disorder marked by high blood glucose concentrations. Both health issues substantially heighten lipid irregularities, rendering lipid testing crucial for prompt identification, risk assessment, therapeutic strategy development, and ongoing observation. Lipid panel testing assists medical professionals in detecting dyslipidemia, directing treatment approaches, and diminishing the likelihood of complications like heart attack and stroke. As an illustration, in September 2025, data from the American College of Cardiology (ACC), a US-based nonprofit medical association, indicated that worldwide cardiovascular disease fatalities totaled $ 0.0192 billion (19.2 million) in 2023. Consequently, the escalating impact of cardiovascular and diabetic conditions is fueling the expansion of the lipid panel testing market.

How Is The Lipid Panel Testing Market Examined Through Segment Analysis?

The lipid panel testing market covered in this report is segmented –

1) By Product And Services: Devices, Kits, Services

2) By Prescription Mode: Prescription-Based Testing, OTC-Based Testing

3) By Application: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo-Lipoproteinemia, Tangier Disease, Atherosclerosis, Other Applications

4) By End User: Hospital, Specialty Clinics And Physician Offices, Pathology Laboratories, Diagnostic Clinics, Reference Laboratories, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Devices: Automated Analyzers, Point-Of-Care Testing Devices, Spectrophotometers

2) By Kits: Test Kits For Cholesterol, HDL And LDL Kits, Triglyceride Test Kits

3) By Services: Laboratory Testing Services, Diagnostic Services, Health Screening Services

Which Trends Are Influencing The Direction Of The Lipid Panel Testing Market?

Companies at the forefront of the lipid panel testing market are directing their efforts toward developing advanced solutions, including Lp(a)-based diagnostic assays, to improve cardiovascular risk assessment. An Lp(a)-based assay is defined as a medical test that measures the concentration of lipoprotein(a) in the blood, allowing healthcare providers to identify individuals facing a heightened risk of cardiovascular diseases and to deliver customized treatment plans. For example, in May 2024, F. Hoffmann-La Roche AG, a biotechnology and diagnostics firm headquartered in Switzerland, launched the Tina-quant Lp(a) RxDx assay after it received FDA Breakthrough Device Designation. This innovation determines the number of Lp(a) molecules per litre in a person’s bloodstream, establishing a standardized and actionable biomarker for cardiovascular risk. Integrated into Roche’s existing serum work area (SWA) systems and cobas® platforms, it enables healthcare professionals to make knowledgeable decisions regarding Lp(a)-lowering therapies, leading to better patient outcomes and supporting precise cardiovascular care. The assay simplifies Lp(a) testing, enhances diagnostic accuracy, and facilitates the wider implementation of personalized lipid management approaches.

Which Companies Are Influencing The Lipid Panel Testing Market?

Major companies operating in the lipid panel testing market are Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics LLC

Access The Complete Lipid Panel Testing Market Report:

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Which Region Contributes The Most To The Lipid Panel Testing Market?

North America was the largest region in the lipid panel testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the global lipid panel testing market during the forecast period. The regions covered in the lipid panel testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Lipid Panel Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Browse Through More Reports Similar to the Global Lipid Panel Testing Market 2026, By The Business Research Company

Lipid Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-global-market-report

Lipid Disorder Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-disorder-treatment-global-market-report

Lipid Regulators Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-regulators-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795